Medline Industries Plans $5B IPO in 2025 with Possible Market Value of $50B

Medline Industries is planning a $5 billion IPO in Q2 2025, valuing the company at $50 billion. The medical supply company is owned by private-equity firms Blackstone, Carlyle, and Hellman & Friedman, who purchased it in a $34 billion deal in 2021. Medline Industries reported revenue of $21.2 billion in 2023, an 81.2% increase from 2019, outpacing rival Medtronic's 2.05% growth.

Medline Industries, a leading global manufacturer and distributor of medical supplies, is reportedly planning to go public with an initial public offering (IPO) valued at over $5 billion in the second quarter of 2025 [1]. This highly anticipated event, which could value the company at around $50 billion, comes after its acquisition by private equity giants Blackstone, Carlyle, and Hellman & Friedman in a $34 billion deal in 2021 [1].

The Northfield, Illinois-based company, which employs approximately 43,000 people worldwide and operates in over 100 countries, has experienced remarkable growth since its acquisition. In 2023, Medline reported revenue of $21.2 billion, representing an impressive 81.2% increase from 2019 [1]. This growth outpaced that of its rival, Medtronic, which experienced a modest 2.05% growth during the same period [1].

Medline's IPO is expected to be one of the most significant in the healthcare sector in recent years. The company's vast product range includes surgical equipment, gloves, and laboratory devices used by hospitals worldwide [1]. With its robust financial performance and the continued demand for healthcare supplies, the IPO is likely to garner significant interest from investors.

The IPO process is well underway, with several investment banks reportedly invited to pitch for lead roles [1]. Medline's private equity owners, Blackstone, Carlyle, and Hellman & Friedman, are expected to maintain significant stakes in the company following the IPO [1].

Medline's growth trajectory and the potential benefits of its IPO make it an exciting development for the healthcare supply industry. As the company prepares to enter the public market, it is poised to continue its role as a key player in the global healthcare supply chain.

References:
[1] Echo Wang. "Exclusive: Medical supplier Medline aims to raise over $5 billion in 2025 IPO - sources." Reuters. October 6, 2022. https://www.reuters.com/business/healthcare-pharmaceuticals/exclusive-medical-supplier-medline-aims-to-raise-over-5-billion-in-2025-ipo-sources-say-2022-10-06/